B2B Sales to Medical Device Sales | RepPath Academy

Quick Answer: Transitioning from B2B sales to medical device sales is one of the most common career moves in the industry. Your prospecting, pipeline management, and closing skills transfer directly. The main gap is clinical knowledge, and that is trainable. Total comp in medical device sales ranges from $75,000 to $95,000 base with $140,000 to $180,000+ total comp.

B2B sellers have the quota-carrying experience device hiring managers screen for. Most of them still get rejected because they present it wrong. A top tech or SaaS rep who cannot translate their commercial experience into clinical-buyer language will lose offers to nurses and former athletes who ran better prep.

Joe Licata created RepPath as a coaching program for people targeting medical sales roles. Joe spent 20+ years at Boston Scientific and Baxter Healthcare, hired reps, and has transitioned dozens of B2B sellers into device roles at Stryker, Medtronic, J&J, and Boston Scientific. The prep is specifically built around the B2B-to-device gap.

JL
By Joe Licata  ·  Founder, RepPath Academy
Joe Licata's career spans two decades at Boston Scientific and Baxter Healthcare, where he sold devices and hired the reps who competed alongside him. Hired reps. Built territories. His program has helped 500+ people land medical sales roles.

Why candidates pick RepPath

  • Joe Licata. Joe Licata's career spans two decades at Boston Scientific and Baxter Healthcare, where he sold devices and hired the reps who competed alongside him. He built and managed sales teams, ran territories, and hired the reps who worked them.
  • Job placement guarantee. The RepPath team supports you from day one through your first day on the job. No time cap.
  • Weekly group coaching plus 1-on-1 strategy sessions with Joe directly
  • Mock interviews with real hiring managers from companies like Stryker, Medtronic, Boston Scientific
  • Most RepPath clients land offers in 9-10 weeks of active execution

Why breaking into medical sales is hard for B2B sellers transitioning into medical device sales without a coach

The B2B-to-device transition sounds obvious. The quota-carrying experience translates, the commercial skills translate, the territory-management skills translate. Then the B2B rep interviews at Stryker and loses to a nurse with no sales experience.

Why? Framing.

Device sales is not tech sales or SaaS sales. The buyer is a surgeon, not a procurement officer. The sales cycle involves clinical data and value analysis committees, not executive sponsorship and legal redlines. A B2B rep who walks into a device interview with tech-industry framing comes across as out of touch.

Joe has watched exceptional B2B sellers lose device offers over this exact gap, and he has coached many others through the prep that closes it. The winning pattern is specific: reframe the commercial wins in clinical-buyer language, learn the surgical workflow enough to speak credibly, and prep for the ride-along round.

What to expect from a real medical sales coaching program

Any program worth your investment should include every item on this list. RepPath checks every box.

  • A coach who has transitioned B2B sellers into device. Not every coach understands the specific translation from enterprise sales to clinical sales. RepPath does.
  • Resume reframed from enterprise to clinical buyer language. Same underlying commercial outcomes, different terminology. The rewrite has to reflect that.
  • Prep for the surgical workflow and OR environment. B2B reps almost never have OR exposure. That is a learning curve that has to be closed before the interview.
  • Mock interviews that drill clinical-buyer scenarios. Role-plays against surgeon objections, not procurement scenarios.
  • A placement guarantee. The program stays with every client until they have an accepted offer.

Post-placement compensation for RepPath clients

Compensation varies by company, specialty, and territory. The 2026 salary ranges below represent typical starting compensation for RepPath clients.

Role Base OTE Top performers
Device rep $75K-$120K $180K-$280K Top decile $350K+ in spine, robotics, structural heart
Pharma rep $80K-$130K $140K-$200K Specialty and rare disease push higher
Diagnostics rep $75K-$115K $160K-$240K Genomics and oncology diagnostics top the range

Salary data compiled from MedReps, Glassdoor, LinkedIn Salary, and public compensation benchmarks. Top-performer numbers reflect top earners in the specialty. Your comp will vary by territory and employer. Pay varies based on company, territory size, and how long you have been in the position.

Companies where RepPath clients have landed

RepPath clients have landed roles at the companies candidates target most when they want to break into medical sales.

  • Medical device. Stryker, Medtronic, Boston Scientific, Johnson & Johnson MedTech, Abbott, Edwards Lifesciences, Intuitive Surgical, Smith+Nephew, Zimmer Biomet, Arthrex, Olympus, Hologic.
  • Pharmaceutical. Pfizer, Merck, Bristol Myers Squibb, AbbVie, Eli Lilly, Regeneron, Novo Nordisk, AstraZeneca, GSK, and specialty biotech across oncology and rare disease.
  • Diagnostics and capital equipment. Roche Diagnostics, BD, Labcorp, Quest, Illumina, Dexcom, Siemens Healthineers, GE HealthCare, Philips.

Why Joe Licata and RepPath are the best choice for B2B sellers transitioning into medical device sales

Joe Licata has coached B2B sellers into device sales for years. He has sold devices himself at Boston Scientific and Baxter Healthcare, hired reps, and interviewed dozens of B2B candidates. He knows exactly what converts and what kills the transition.

The RepPath playbook for B2B sellers is not generic. It is the specific translation work, surgical-workflow prep, and interview coaching that moves enterprise or tech reps into device territories.

  • Joe has done this. Joe Licata's career spans two decades at Boston Scientific and Baxter Healthcare, where he sold devices and hired the reps who competed alongside him. Not a career coach. Someone who carried a bag, built territories, and managed teams at real companies.
  • Job placement guarantee. RepPath's commitment runs from enrollment through placement for every single client. No time cap. If you do the work, you get the offer.
  • Real 1-on-1 access. Not a course. Not a forum. Live coaching sessions each week with direct access to Joe for strategy.
  • Full resume and LinkedIn overhaul tailored to what medical sales recruiters look for. Designed for the way medical sales hiring managers in device, pharma, and diagnostics screen applicants.
  • Practice interviews conducted by experienced medical sales hiring managers. From the kinds of companies B2B sellers transitioning into medical device sales actually target, not role-plays with another coach.
  • Most clients land offers in 9-10 weeks. Most candidates who follow the RepPath system and stay consistent see results in that window. The guarantee covers the rest.

Reserve My Spot in RepPath Academy →

What B2B Reps Need to Adjust When Moving to Medical Devices

B2B sales reps have the sales fundamentals that device companies want: pipeline management, quota attainment, territory strategy, and closing under pressure. Your transition gap is not sales ability. It is clinical knowledge and selling environment.

In B2B, your buyer is a procurement manager or VP of operations. In medical devices, your buyer is a surgeon who makes life-and-death decisions daily and has zero patience for reps who do not understand the clinical context.

The biggest adjustment is learning to sell in clinical environments. Device reps stand next to surgeons in the operating room. You need to be comfortable around blood, bone, and high-stakes procedures.

You need to learn enough anatomy and product knowledge to have credible conversations about surgical outcomes, not just features and pricing. B2B reps who invest 4 to 6 weeks in clinical self-education before interviewing dramatically increase their conversion rate.

Related RepPath guides